Efficacy and Safety of JAK Inhibitors in Psoriatic Disease There is a growing body of evidence demonstrating efficacy and safety of JAK inhibitors in patients with moderate-to-severe PSO and PsA, according to a systematic review in BMC Rheumatology. https://t.co/8Y4V1jUlzo https://t.co/eFqknUfGat